GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PT Bundamedik Tbk (ISX:BMHS) » Definitions » EV-to-EBITDA

PT Bundamedik Tbk (ISX:BMHS) EV-to-EBITDA : 18.32 (As of May. 24, 2024)


View and export this data going back to 2021. Start your Free Trial

What is PT Bundamedik Tbk EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, PT Bundamedik Tbk's enterprise value is Rp3,900,473 Mil. PT Bundamedik Tbk's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was Rp212,948 Mil. Therefore, PT Bundamedik Tbk's EV-to-EBITDA for today is 18.32.

The historical rank and industry rank for PT Bundamedik Tbk's EV-to-EBITDA or its related term are showing as below:

ISX:BMHS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.74   Med: 14.29   Max: 26.79
Current: 18.15

During the past 6 years, the highest EV-to-EBITDA of PT Bundamedik Tbk was 26.79. The lowest was 9.74. And the median was 14.29.

ISX:BMHS's EV-to-EBITDA is ranked worse than
67.24% of 464 companies
in the Healthcare Providers & Services industry
Industry Median: 12.94 vs ISX:BMHS: 18.15

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-24), PT Bundamedik Tbk's stock price is Rp338.00. PT Bundamedik Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was Rp0.738. Therefore, PT Bundamedik Tbk's PE Ratio for today is 457.99.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


PT Bundamedik Tbk EV-to-EBITDA Historical Data

The historical data trend for PT Bundamedik Tbk's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Bundamedik Tbk EV-to-EBITDA Chart

PT Bundamedik Tbk Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - - 13.25 12.65 19.46

PT Bundamedik Tbk Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.90 15.08 20.89 19.46 19.66

Competitive Comparison of PT Bundamedik Tbk's EV-to-EBITDA

For the Medical Care Facilities subindustry, PT Bundamedik Tbk's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Bundamedik Tbk's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Bundamedik Tbk's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where PT Bundamedik Tbk's EV-to-EBITDA falls into.



PT Bundamedik Tbk EV-to-EBITDA Calculation

PT Bundamedik Tbk's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=3900472.829/212948.338
=18.32

PT Bundamedik Tbk's current Enterprise Value is Rp3,900,473 Mil.
PT Bundamedik Tbk's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp212,948 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Bundamedik Tbk  (ISX:BMHS) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

PT Bundamedik Tbk's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=338.00/0.738
=457.99

PT Bundamedik Tbk's share price for today is Rp338.00.
PT Bundamedik Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0.738.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


PT Bundamedik Tbk EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of PT Bundamedik Tbk's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Bundamedik Tbk (ISX:BMHS) Business Description

Traded in Other Exchanges
N/A
Address
Jl. Teuku Cik Ditiro No.28, Menteng, Jakarta Pusat, IDN, 10350
PT Bundamedik Tbk is a healthcare service provider. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.

PT Bundamedik Tbk (ISX:BMHS) Headlines

No Headlines